Autres langues Integrated BioPharma, Inc.

Actions

INBP

US45811V1052

Temps Différé OTC Markets Autres places de cotation 15:38:40 29/05/2024			Varia. 5j.	Varia. 1 janv.
0,25 ^USD	-.--%		-.--%	+1,96%

10/05	Integrated BioPharma, Inc. annonce ses résultats pour le troisième trimestre et les neuf mois clos le 31 mars 2024	CI
12/02	Integrated BioPharma, Inc. annonce ses résultats pour le deuxième trimestre et le semestre clos le 31 décembre 2023	CI

Autres langues

Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !

Inscription 100% Gratuite

Integrated BioPharma Reports Results for its Quarter Ended March 31, 2024	13/05
Integrated BioPharma, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2024	10/05
Integrated BioPharma, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023	12/02
Integrated BioPharma, Inc. Reports Earnings Results for the First Quarter Ended September 30, 2023	09/11
Integrated BioPharma, Inc. Reports Earnings Results for the Fourth Quarter Ended June 30, 2023	15/09/23
Integrated BioPharma, Inc. Reports Earnings Results for the Full Year Ended June 30, 2023	15/09/23
Integrated BioPharma, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2023	11/05/23
INTEGRATED BIOPHARMA INC : Other Events, Financial Statements and Exhibits (form 8-K)	21/03/23
Integrated BioPharma, Inc. Announces the Death of Edward G. Kay, Executive Chairman and President	21/03/23
Integrated BioPharma, Inc. Enters into Fourth Amendment to Revolving Credit, Term Loan and Security Agreement	17/03/23
INTEGRATED BIOPHARMA INC MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANICAL CONDITION AND RESULTS OF OPERATION (dollars in thousands) (form 10-Q)	10/02/23
Integrated BioPharma, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2022	10/02/23
Integrated BioPharma : Submission of Matters to a Vote of Security Holders - Form 8-K	28/11/22
INTEGRATED BIOPHARMA INC : Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits (form 8-K)	28/11/22
INTEGRATED BIOPHARMA INC MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANICAL CONDITION AND RESULTS OF OPERATION (dollars in thousands) (form 10-Q)	10/11/22
Integrated BioPharma, Inc. Reports Earnings Results for the First Quarter Ended September 30, 2022	10/11/22
INTEGRATED BIOPHARMA INC : Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits (form 8-K)	24/10/22
INTEGRATED BIOPHARMA INC Management's Discussion and Analysis of Financial Condition and Results of Operations (dollars in thousands). (form 10-K)	13/09/22
Integrated BioPharma, Inc. Reports Earnings Results for the Full Year Ended June 30, 2022	13/09/22
INTEGRATED BIOPHARMA INC : Termination of a Material Definitive Agreement (form 8-K)	15/07/22

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Integrated BioPharma, Inc.

Actions

INBP

US45811V1052

Autres langues

Filtres